Taxane platinum combination chemotherapy versus single agent platinum for the first line treatment of epithelial ovarian cancer
Editorial Group: Cochrane Gynaecological Cancer Group
Published Online: 12 DEC 2012
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Johnson N, Miles T, Cornes P, Gilby E. Taxane platinum combination chemotherapy versus single agent platinum for the first line treatment of epithelial ovarian cancer (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD010194. DOI: 10.1002/14651858.CD010194.
- Publication Status: New
- Published Online: 12 DEC 2012
This is the protocol for a review and there is no abstract. The objectives are as follows:
To evaluate the benefit and harms of adding a taxane to platinum therapy compared to platinum chemotherapy alone for the primary management of epithelial ovarian, fallopian tube or peritoneal epithelial adenocarcinoma.